Results 201 to 210 of about 14,831 (254)
Some of the next articles are maybe not open access.
Pharmacokinetics of intranasal corticosteroids
Journal of Allergy and Clinical Immunology, 2001Topical administration of corticosteroids can reduce the total dose of corticosteroid required to treat the patient and minimize side effects. This logic has led to the development of intranasal corticosteroids (INCS) for allergic and perennial rhinitis.
openaire +2 more sources
Intranasal corticosteroids and cromolyn
American Journal of Otolaryngology, 1993A substantial portion of the practice of the general otolaryngologist involves the management of rhinitis. Two types of therapeutic agents that are important tools for treating this disorder are topically applied corticosteroids and mast cell stabilizers (eg, cromolyn). However, confusion continues to exist as to the proper use of these agents.
openaire +2 more sources
Mode of action of intranasal corticosteroids
Journal of Allergy and Clinical Immunology, 2001The mode of action of intranasal corticosteroids (INCS) is complex. It is not known whether INCS penetrate the nasal mucosa or act on target cells; however, their low systemic activity supports the concept of local action on nasal mucosa. This local effect can nonetheless influence a variety of inflammatory cells and their mediators such as epithelial ...
Mygind, N +6 more
openaire +3 more sources
Safety of intranasal corticosteroids
Annals of Allergy, Asthma & Immunology, 2016Concurrent use of intranasal corticosteroids (INCSs) and inhaled corticosteroids (ICSs) is indicated for patients who are comorbid for asthma and allergic rhinitis. Clinicians need to know the data regarding INCS safety for their patients with asthma.To discuss INCS safety data for the use of INCSs in patients with asthma and allergic rhinitis.INCS ...
openaire +2 more sources
Precautions for Intranasal Corticosteroid Injection
JAMA: The Journal of the American Medical Association, 1989To the Editor.— The Photo/Essay "Visual Loss Following Intranasal Corticosteroid Injection" by Drs Johns and Chandra 1 in the April 28 issue of JAMA was a striking example of documentation of an extremely rare but potentially catastrophic sequela of intraturbinal corticosteroid injection.
openaire +2 more sources
Immunologic Effects of Intranasal Corticosteroids
Allergy and Asthma Proceedings, 1996Intranasally administered corticosteroids have a wide margin of safety and are the mainstay of treatment for patients with moderate to severe allergic rhinitis, nonallergic rhinitis, and nasal polyposis. Long term use in recommended dosages has not caused nasal mucosal atrophy or hypothalamic-pituitary-adrenal (HPA) suppression.
Toby Levenson, Paul A. Greenberger
openaire +1 more source
Can Intranasal Corticosteroids Cause Migraine-Like Headache?
Cephalalgia, 2009Intranasal corticosteroids (INCs) act predominantly locally and are considered to exert minimal systemic effects. On reviewing the international data collected in the World Health Organization's global pharmacovigilance programme an unexpected cluster was found of 38 case reports of migraine in suspected connection with INCs.
J, Pokladnikova +3 more
openaire +2 more sources
Severe chickenpox after intranasal use of corticosteroids
The Journal of Pediatrics, 1993Two children were hospitalized for severe chickenpox after intranasal use of corticosteroids for chronic sinusitis. One had unusually extensive cutaneous disease with delayed progression of lesions, dehydration, and prolonged fever; the other had hemorrhagic cutaneous lesions, hepatitis, and pneumonitis.
M J, Abzug, M F, Cotton
openaire +2 more sources
Intranasal corticosteroids: Do they improve ocular allergy?
Current Allergy and Asthma Reports, 2009Allergic rhinoconjunctivitis (ARC) is a commonallergic condition associated with high financial costs and decreased quality of life. Medical treatment options are extensive and include oral, ophthalmic, and intranasal agents. Intranasal corticosteroids (INS) have traditionally been used for chronic management of nasal symptoms, but have also ...
Catherine, Origlieri, Leonard, Bielory
openaire +2 more sources
Use of intranasal corticosteroids in adenotonsillar hypertrophy
The Journal of Laryngology & Otology, 2017AbstractObjectives:This review examined the efficacy of intranasal corticosteroids for improving adenotonsillar hypertrophy.Method:The related literature was searched using PubMed and Proquest Central databases.Results:Adenotonsillar hypertrophy causes mouth breathing, nasal congestion, hyponasal speech, snoring, obstructive sleep apnoea, chronic ...
Sakarya, E. U. +6 more
openaire +3 more sources